Kirsi Granberg
Kirsi Granberg
Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland
Verified email at - Homepage
Cited by
Cited by
The tumorigenic FGFR3-TACC3 gene fusion escapes miR-99a regulation in glioblastoma
BC Parker, MJ Annala, DE Cogdell, KJ Granberg, Y Sun, P Ji, X Li, ...
The Journal of clinical investigation 123 (2), 2013
An insight into molecular mechanisms of human T helper cell differentiation
KJ Rautajoki, KJ Rautajoki, MK Kyläniemi, SK Raghav, K Rao, ...
Annals of medicine 40 (5), 322-335, 2008
Two mature products of MIR-491 coordinate to suppress key cancer hallmarks in glioblastoma
X Li, Y Liu, KJ Granberg, Q Wang, LM Moore, P Ji, J Gumin, EP Sulman, ...
Oncogene 34 (13), 1619-1628, 2015
Genomically amplified Akt3 activates DNA repair pathway and promotes glioma progression
KM Turner, Y Sun, P Ji, KJ Granberg, B Bernard, L Hu, DE Cogdell, ...
Proceedings of the National Academy of Sciences 112 (11), 3421-3426, 2015
Immunogenomic landscape of hematological malignancies
O Dufva, P Pölönen, O Brück, MAI Keränen, J Klievink, J Mehtonen, ...
Cancer Cell 38 (3), 380-399. e13, 2020
A proteome database of human primary T helper cells
TA Nyman, A Rosengren, S Syyrakki, TP Pellinen, K Rautajoki, ...
Electrophoresis 22 (20), 4375-4382, 2001
IGFBP2 potentiates nuclear EGFR–STAT3 signaling
CY Chua, Y Liu, KJ Granberg, L Hu, H Haapasalo, MJ Annala, ...
Oncogene 35 (6), 738-747, 2016
Proteome characterization of human T helper 1 and 2 cells
K Rautajoki, TA Nyman, R Lahesmaa
Proteomics 4 (1), 84-92, 2004
Interleukin-4 inhibits caspase-3 by regulating several proteins in the Fas pathway during initial stages of human T helper 2 cell differentiation
KJ Rautajoki, EM Marttila, TA Nyman, R Lahesmaa
Molecular & Cellular Proteomics 6 (2), 238-251, 2007
Computational characterization of suppressive immune microenvironments in glioblastoma
S Luoto, I Hermelo, EM Vuorinen, P Hannus, J Kesseli, M Nykter, ...
Cancer research 78 (19), 5574-5585, 2018
Recurrent SKIL-activating rearrangements in ETS-negative prostate cancer
M Annala, K Kivinummi, J Tuominen, S Karakurt, K Granberg, L Latonen, ...
Oncotarget 6 (8), 6235, 2015
Twist predicts poor outcome of patients with astrocytic glioma
K Nordfors, J Haapasalo, K Mäkelä, KJ Granberg, M Nykter, M Korja, ...
Journal of clinical pathology 68 (11), 905-912, 2015
Strong FGFR3 staining is a marker for FGFR3 fusions in diffuse gliomas
KJ Granberg, M Annala, B Lehtinen, J Kesseli, J Haapasalo, ...
Neuro-oncology 19 (9), 1206-1216, 2017
Genetic and Epigenetic Characteristics of Inflammatory Bowel Disease–Associated Colorectal Cancer
K Rajamäki, A Taira, R Katainen, N Välimäki, A Kuosmanen, RM Plaketti, ...
Gastroenterology 161 (2), 592-607, 2021
Hemap: An interactive online resource for characterizing molecular phenotypes across hematologic malignancies
P Pölönen, J Mehtonen, J Lin, T Liuksiala, S Häyrynen, S Teppo, ...
Cancer research 79 (10), 2466-2479, 2019
Overexpression of SNORD114-3 marks acute promyelocytic leukemia
T Liuksiala, KJ Teittinen, K Granberg, M Heinäniemi, M Annala, M Mäki, ...
Leukemia 28 (1), 233-236, 2014
Single-cell ATAC and RNA sequencing reveal pre-existing and persistent cells associated with prostate cancer relapse
S Taavitsainen, N Engedal, S Cao, F Handle, A Erickson, S Prekovic, ...
Nature communications 12 (1), 1-16, 2021
Community assessment of the predictability of cancer protein and phosphoprotein levels from genomics and transcriptomics
M Yang, F Petralia, Z Li, H Li, W Ma, X Song, S Kim, H Lee, H Yu, B Lee, ...
Cell systems 11 (2), 186-195. e9, 2020
Glioblastoma Multiforme Stem Cell Cycle Arrest by Alkylaminophenol through the Modulation of EGFR and CSC Signaling Pathways
P Doan, A Musa, A Murugesan, V Sipilä, NR Candeias, F Emmert-Streib, ...
Cells 9 (3), 681, 2020
Clinical association analysis of ependymomas and pilocytic astrocytomas reveals elevated FGFR3 and FGFR1 expression in aggressive ependymomas
B Lehtinen, A Raita, J Kesseli, M Annala, K Nordfors, O Yli-Harja, ...
BMC cancer 17 (1), 1-12, 2017
The system can't perform the operation now. Try again later.
Articles 1–20